baber/WOPTO huggingface dataset:
Patent AU-2018441779-B2 (AU)
Title: Resource allocation method, terminal device, and network device
Inventor: TANG HAI
IPC: H04W72/04
Filed: 2018-09-18
Granted: 2022-07-14
Abstract: Provided in the embodiments of the present application are a resource allocation method, a terminal device, and a network device; when the unit of resource allocation is an interlace structure, as an NR-U system can support multiple subcarrier intervals, on the configured BWP, configuring different offset values for different subcarrier intervals enables the initial position of the interlace under different subcarrier intervals to be the same, facilitating resource allocation by the network device, or the PRB that cannot be divided by interlaces to be reserved in a middle position of the bandwidth, facilitating PRACH with a continuous allocation of transmission resources. The method comprises: a terminal device receives first indication information sent by a network device, the first indication information being used for determining the frequency domain unit included in a first interlace on a first BWP; and, on the basis of the first indication information, the terminal device determines the frequency domain unit included in the first interlace.
Patent AU-2018452256-B2 (AU)
Title: Logic circuitry
Inventor: PANSHIN STEPHEN D
IPC: G06F21/74
Filed: 2018-12-03
Granted: 2022-09-08
Abstract: In an example, a logic circuitry package has a first address and comprises a first logic circuit. In some examples, the first address is an I2C address for the first logic circuit, and the package is configured such that, in response to a first command indicative of a task and a first time period sent to the first address, the first logic circuit is to, for a duration of the time period, perform a task, and disregard I2C traffic sent to the first address.
Patent AU-2019276924-B2 (AU)
Title: Seating arrangement
Inventor: DEEVERS NICKOLAUS WILLIAM CHARLES
IPC: A47C1/03
Filed: 2019-05-23
Granted: 2023-07-20
Abstract: An arm assembly includes an arm support configured to support an arm of a seated user, an arm stalk extending downwardly from and supporting the arm support, an arm base telescopingly receiving the arm stalk between a first position and a second position and a bearing arrangement positioned between the arm stalk and the arm base. The bearing arrangement includes a bearing member configured to abut the arm base, and a biasing member configured to bias the bearing member from the arm stalk and into abutment with the arm base.
Patent AU-2019291054-B2 (AU)
Title: Multichannel audio coding
Inventor: BÜTHE JAN
IPC: G10L19/02
Filed: 2019-06-19
Granted: 2022-04-07
Abstract: In multichannel audio coding, improved computational efficiency is achieved by computing comparison parameters for
Patent AU-2019291812-B2 (AU)
Title: Systems, devices, and methods for treatment of nasal disorders
Inventor: FAHEY BRIAN
IPC: A61B18/02
Filed: 2019-06-26
Granted: 2022-06-16
Abstract: Systems, devices, and methods involve ablation of tissue to treat rhinitis and/or other nasal conditions. Implementations allow treatment of tissue in the confined space of the nasal cavity. Additionally, implementations allow targeted treatment tissue to be ablated, while protecting other non-treatment tissue from unintentional collateral effects that might be produced by the ablation. According to an example implementation, an approach for treating a nasal condition includes advancing a probe into a nasal cavity, the probe including a shaft and a cryotherapy element coupled to the shaft. The approach also includes cryogenically cooling a target treatment site with the cryotherapy element to treat at least one nasal nerve. Additionally, the approach includes transmitting a focused ultrasound beam to a target heating site to increase a temperature tissue at the target heating site.
Patent AU-2019310704-B2 (AU)
Title: Method for preparing trifluridine
Inventor: LIU LIN
IPC: C07H19/073
Filed: 2019-07-24
Granted: 2022-05-19
Abstract: The present application relates to a method for preparing trifluridine, comprising reacting a compound of formula III with a compound of formula IV in a first solvent in the presence of an acid to obtain a compound of formula II, and performing further reaction to obtain trifluridine.
Patent AU-2019431082-B2 (AU)
Title: Composition, for preventing, relieving or treating cartilage-related diseases or symptoms, comprising HAPLN1
Inventor: KIM DAE KYONG
IPC: A23L33/10
Filed: 2019-02-28
Granted: 2022-12-15
Abstract: The present invention relates to a composition, for preventing, relieving or treating cartilage-related diseases or symptoms, comprising hyaluronan and proteoglycan link protein 1 (HAPLN1) as an active ingredient. Specifically, the present invention provides a composition for regenerating cartilage, a composition for preventing, relieving or treating osteoarthritis or a composition for regenerating growth plate cartilage, which comprise HAPLN1 as an active ingredient.
Patent AU-2020200699-B2 (AU)
Title: Methods and compositions for modulating splicing
Inventor: LUZZIO Michael
IPC: A61K31/439
Filed: 2020-01-30
Granted: 2021-03-25
Abstract: METHODS AND COMPOSITIONS FOR MODULATING SPLICING 
ABSTRACT 
Described herein are small molecule splicing modulator compounds that modulate splicing of 
mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing 
modulator compounds for modulating splicing and treating diseases and conditions.  
- 435-
Patent AU-2020202170-B2 (AU)
Title: Method and system for data transmitting and displaying
Inventor: RAFIZADEH CYRUS SHERWIN
IPC: G09F27/00
Filed: 2020-03-26
Granted: 2021-12-16
Abstract: A method of data transmitting and displaying content is disclosed. In an embodiment, a 
method comprises a data providing unit selecting one or more data displaying units. The 
data providing unit provides, to a data processing unit, content for display on the selected 
10 one or more data displaying units. The data processing unit communicates the provided 
content to the selected one or more data displaying units for display and establishes a 
direct data communication channel between the data providing unit and each of the 
selected one or more data displaying units. The direct data communication channel 
enables the data providing unit to adjust the content provided for display during or prior 
15 to displaying the content.
1/4 
110 
Presenting comprehensively by a data processing party information 
about data displaying parties 
Selecting a data displaying party according to the presented 1 
information about the data displaying parties and uploading data to 
be displayec by a data provider 
Instructing by the data processing party the selected data displaying party 130 
to display the data uploaded by the data provider establishing a direct link 
between the data provider and the selected data displaying party and 
granting a permission for the data provider to adjust the data displaying of 
the selected data displaying party 
Figure 1 
Sending by the data provider a displaying request which includes S1211 
specific location of the data displaying party desired for data 
displaying to the data processing party 
Receiving displaying feedback information from the data processing S1212 
party if it is confirmed that the data displaying can be performed at 
the specific locatior proceeding to step S1213 
S1213 
Uploading the data to be displayed to the data processing party by 
the data provider 
Figure 2
Patent AU-2020250201-B2 (AU)
Title: Bicyclic heterocycles as fgfr inhibitors
Inventor: SUN YAPING
IPC: A61P3/00
Filed: 2020-10-07
Granted: 2022-07-07
Abstract: The present invention relates to bicyclic heterocycles, and pharmaceutical 
compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in 
the treatment of FGFR-associated diseases such as cancer.
Patent AU-2020277165-B2 (AU)
Title: Feline calicivirus vaccine
Inventor: SHEHU ERALD
IPC: C12N7/04
Filed: 2020-11-25
Granted: 2021-08-19
Abstract: Feline calicivirus vaccine.  
Abstract 
The present invention relates to a new feline capsid protein, to live attenuated feline calicivirus 
comprising that capsid protein, to live recombinant carrier viruses and live attenuated hybrid 
feline calicivirus comprising that capsid protein, to vaccines comprising such live attenuated 
feline caliciviruses, live recombinant carrier viruses and live attenuated hybrid feline calicivirus, 
and to methods for the preparation of such viruses.
Patent AU-2020304356-B2 (AU)
Title: Systems and methods for detecting missed bolus doses
Inventor: JOHNSON JENNAL LYNN
IPC: G16H20/10
Filed: 2020-06-19
Granted: 2023-07-20
Abstract: Methods, systems and devices are provided for dynamically adjusting sensitivity of a computer-implemented detector for detecting missed insulin boluses. The disclosed methods, systems, and devices receive glucose measurements and insulin dosing information for a user, and analyze the received information to detect whether the user may have ingested food without taking an insulin bolus. The sensitivity level of the detector may be dynamically adjusted based on contextual information regarding the user to adjust for the users context, circumstances, and/or condition. If the detector detects a possible missed bolus, the detector may generate a user notification.
Patent AU-2020327082-B2 (AU)
Title: Target parameter determination method, communication node and storage medium
Inventor: ZHANG SHUJUAN
IPC: H04L5/00
Filed: 2020-07-30
Granted: 2023-07-13
Abstract: Disclosed are a target parameter determination method, a communication node and a storage medium. The target parameter determination method comprises: determining N types of information, wherein N is a positive integer, and there is a mapping relationship between the N types of information and a first type set; and determining a target parameter according to the N types of information, wherein the target parameter comprises at least one of a hybrid automatic repeat request acknowledgement (HARQ-ACK) parameter and a channel parameter.
Patent AU-2021202727-B2 (AU)
Title: Flavor Infused Alcoholic Beverage And Method Of Making The Same
Inventor: HALL DOUGLAS B
IPC: C12H1/00
Filed: 2021-04-30
Granted: 2023-03-09
Abstract: The present invention is an alcoholic beverage having the sensory characteristics of a 
flavored distilled spirit. The method of making the alcoholic beverage includes suspending 
botanicals above a distilled spirit in a closed container and applying pressure to create 
interaction between the botanicals and distilled spirit.
Patent AU-2021236510-B2 (AU)
Title: Tufting system
Inventor: PONGRASS ROBERT GABOR
IPC: D05C15/18
Filed: 2021-09-23
Granted: 2022-02-10
Abstract: A tufting needle (100) is disclosed. The tufting needle comprises a shaft (101) 
having a tapered formation (103) configured to penetrate and open a passage (105) in a 
resilient backing material (107). Needle (100) further comprises a filament lumen (109) that 
leads to an opening (117) proximal to the tapered formation (103), and to guide a filament 
(111) through the passage (105) to create a tuft (113) at the resilient backing material (107).  
A cutting edge (115) is located at the opening (117) of the filament lumen (109) to cut the 
filament (111).
1/9 
100 
141 
138 101 123 
-yA 1124.  
131 
121 
103 
A 115 129 131 
143Fi 1A 
Fig.I1A
Patent AU-2021288087-B2 (AU)
Title: Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
Inventor: SHAH PARAG
IPC: A61K9/28
Filed: 2021-06-10
Granted: 2023-03-30
Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of,
Patent AU-2022221384-B2 (AU)
Title: Use of Nicotinic acid Riboside or Nicotinamide Ribosite derivatives, and reduced derivatives thereof, as nad+ increasing precursors
Inventor: MORRIS MARK
IPC: A61K31/44
Filed: 2022-08-22
Granted: 2023-03-23
Abstract: Compositions are provided including nicotinic acid riboside ("NAR"), and derivatives thereof including 1 -(2',3 
,5'-triacetyl-beta-D-ribofuranosyl)-nicotinic acid ("NAR triacetate" or "NARTA"); or derivatives of a reduced 
form of nicotinic acid riboside ("NARH"), including 1 - (2',3',5 '-triacetyl-beta-D-ribofuranosyl)-1,4
dihydronicotinic acid ("NARH triacetate" or "NARJT-TA"); or derivatives of nicotinamide riboside ("NR"), 
including 1 -(2',3',5'-triacetyl- beta-D-ribofuranosyl)-nicotinamide ("NR triacetate" or "NRTA"); derivatives of a 
reduced form of nicotinamide riboside ("NRH"), including 1-(2',3 ',5'-triacetyl-beta-D-ribofuranosyl)- 1,4
dihydronicotinamide ("NRH triacetate" or "NRH-TA"); or salts or prodrugs thereof, for use in food or 
beverage applications, pharmaceutical formulations, or as a dietary supplement. Methods of using the 
compounds above to promote the increase of intracellular levels of nicotinamide adenine dinucleotide 
("NAD+") or NADH in cells and tissues for improving cell and tissue survival or overall cell and tissue health 
are provided.
Patent JP-3523821-B2 (JP)
IPC: A61K31/519
Filed: 2000-02-09
Granted: 2004-04-26
Abstract: Provided are a production process for a polymeric micelle which is stable and has a high drug content and a composition containing such polymeric micelle. Disclosed are a production process for a polymeric micelle, comprising the steps of dissolving a drug and a specific copolymer in a water non-miscible organic solvent to prepare a solution, mixing the resulting solution with water to form an O/W type emulsion and then slowly volatilizing the organic solvent from the solution, and a polymeric micelle composition charged therein with a water-scarcely soluble drug, which can be obtained by the above production process.
Patent JP-4997661-B2 (JP)
IPC: C08F283/04
Filed: 2000-03-29
Granted: 2012-08-08
Abstract: PROBLEM TO BE SOLVED: To obtain an imide (amide) resin which is solvent-soluble, can be developed with a dil, aqueous alkali solution, and is excellent in energy ray curabilty and heat resistance by reacting an at least trifunctional aromatic carboxylic acid with a polyisocyanate compound and a compound having a polymerizable double bond and an OH group and/or an epoxy group. SOLUTION: An at least trifunctional aromatic carboxylic acid (anhydride) (e.g. trimellitic anhydride), a polyisocyanate compound (e.g. isophorone diisocyanate), and a compound having at least one polymerizable double bond, preferably at least one (meth)acryloyl group, and an OH group (or an epoxy group) (e.g. pentaerythritol triacrylate) are reacted, Preferably, the resulting resin has an acid value of 10-300 mgKOH/g and a wt. average mol.wt. of 500-50,000. The resin and an organic solvent (a reactive diluent) are compounded to give an energy-ray-curable resin composition.
Patent JP-4928662-B2 (JP)
IPC: G09G3/20
Filed: 2000-04-27
Granted: 2012-05-09
Abstract: With the new plasma display panel technology new kinds of artefacts can occur in video pictures due to the principle that brightness control is done with a modulation of small lighting pulses in a number of periods called sub-fields. These artefacts are commonly described as 'dynamic false contour effect'. A technique called bit line repeat coding has been developed for reducing the false contour effect. According to this technique sub-field coding is done with common (CSF) and normal sub-fields (SF) where for the common sub-fields (CSF) identical entries in the sub-field code words of two or more corresponding pixels on two or more pixel lines are used. In this specific sub-field coding method some cases will occur in which an error has to be made due to the reduced flexibility in encoding produced by the need to have the same code on common sub-fields (CSF). The general idea of the invention is now to put the coding failures on the higher video levels of the two or more pixels being grouped together. Further improvements concern picture content analysis and or motion detection for controlling the switching between different sub-field coding modes and a specific adapted dithering pattern for use with bit line repeat coding. <IMAGE>
Patent JP-4601143-B2 (JP)
IPC: C12N15/09
Filed: 2000-09-25
Granted: 2010-12-22
Abstract: The present invention is drawn to a gene comprising a polynucleotide encoding a polypeptide composed of an amino acid sequence represented by SEQ ID NO: 1; a gene expression product produced through expression of the gene; a recombinant expression vector including the gene; a host cell (transformant) harboring the recombinant expression vector; a protein composed of an amino acid having an amino acid sequence represented by SEQ ID NO: 1; a therapeutic or preventive composition for hypoglycemia containing as an active ingredient the above-mentioned gene or protein; and an antibody capable of binding to the protein. Through use of the gene or an expression product thereof of the present invention, it is possible to elucidate the pathology of diabetes and develop drugs for treatment and prevention of diabetes via a new action mechanism.
Patent JP-4322420-B2 (JP)
IPC: C07D235/02
Filed: 1998-07-22
Granted: 2009-09-02
Abstract: Process for the preparation of compounds of formula (I) wherein R means hydrogen atom, or C1-6 alkyl group, or C7-12 aralkyl group or phenyl group, characterised in that a) the compound of formula (III) is reacted with a compound of formula (IV) wherein X means halogen atom or C1-5 alkoxy group or hydroxyl group, and the resulting compound of formula (II) is transformed, in a reaction medium with pH above 7, into the compound of formula (I) or b) the compound of formula (III) is reacted with an anhydride of general formula (V) and the resulting compound of formula (II) transformed, in a reaction medium with pH above 7, into the compound of formula (I), or c) a compound of formula (II) is transformed, in a reaction medium with pH above 7, into the compound of formula (I), and if desired, the resulting compounds of formula (I), before or after isolation, are transformed into acid addition salts, or the compounds of formula (I) are liberated from their acid addition salts. Thus a process for the preparation of intermediates useful in synthesis of angiotensin II antagonists is disclosed.
Patent JP-4344482-B2 (JP)
IPC: B63C9/08
Filed: 1999-04-12
Granted: 2009-10-14
Abstract: A protective body garment is provided including a vest having a body with arm holes, the vest having an internal surface and an external surface, and a front that, when worn, is adjacent to a wearer's chest and stomach, sides that, when worn, are adjacent to the wearer's sides, a back that, when worn, is adjacent to the wearer's back, and a pair of shoulders that, when worn, are above the wearer's shoulders. The garment further includes penetration resistant armour located under the external surface of the vest and an inflatable flotation bladder in the form of a bag between the inner surface of the vest and the penetration resistant armour.
Patent JP-3848838-B2 (JP)
IPC: C07D221/12
Filed: 2000-03-24
Granted: 2006-11-22
Abstract: A set of 4,7-dichlororhodamine compounds useful as fluorescent dyes are disclosed having the structures <CHEM> wherein R1-R6 are hydrogen, fluorine, chlorine, lower alkyl, lower alkene, lower alkyne, sulfonate, sulfone, amino, amido, nitrile, lower alkoxy, linking group, or, when taken together, R1 and R6 is benzo, or, when taken together, R4 and R5 is benzo; R7-R10, R12-R16 and R18 may be hydrogen, fluorine, chlorine, lower alkyl, lower alkene, lower alkyne, sulfonate, sulfone, amino, amido, nitrile, lower alkoxy, linking group; R11 and R17 may be hydrogen, lower alkyl, lower alkene, lower alkyne, phenyl, aryl, linking group; Y1-Y4 are hydrogen, lower alkyl, or cycloalkyl, or, when taken together, Y1 and R2, Y2 and R1 Y3 and R3, and/or Y4 and R4 is propano, ethano, or substituted forms thereof; and X1-X3 taken separately are hydrogen, chlorine, fluorine, lower alkyl, carboxylate, sulfonate, hydroxymethyl, and linking group, or any combinations thereof. In another aspect, the invention includes reagents labeled with the 4,7-dichlororhodamine dye compounds, including deoxynucleotides, dideoxynucleotides, and polynucleotides. In an additional aspect, the invention includes methods utilizing such dye compounds and reagents including dideoxy polynucleotide sequencing and fragment analysis methods.
Patent JP-3507448-B2 (JP)
IPC: B01L3/00
Filed: 2001-03-02
Granted: 2004-03-15
Abstract: First and/or second components (2, 3) have an exchange region accepting substances from the surrounding fluid. Downstream of this region, a sensor (15) determines analyte concentration. Integral reservoirs (6, 11,19) of the system are connected with the channel (7, 8, 10).
Patent JP-5107492-B2 (JP)
IPC: B23K9/173
Filed: 2001-09-06
Granted: 2012-12-26
Abstract: A method for the MIG welding of nickel and some nickel alloys, with a protective gas in a least a part of the welding zone, uses a protective gas containing a mixture of 0.05 to 0.5% of CO2 and argon.   Advantageously, the gas mixture also contains 15 to 50% vol. and preferably 17 to 30% vol. Helium or 0.1 to 10% vol. and preferably 1 to 7% vol. Hydrogen. Independent claims are included for gas mixtures used as the protective atmosphere for the MIG welding of nickel and some nickel alloys.
Patent JP-4578041-B2 (JP)
IPC: A61B5/117
Filed: 2000-08-09
Granted: 2010-11-10
Abstract: A piezoelectric thin film sensor array is used to scan and capture biometric data, for example, a fingerprint image. In one embodiment, a multi-layer structure includes a PVDF layer in between two conductor grids arranged orthogonally to one another. Urethane can be added to one side where a finger is placed. A foam substrate can be used as a support. In one feature, the PVDF, and grids can be peeled off like a label for easy replacement. Multiplexers are switched to scan the sensor. A single pixel or a group of pixels can be detected and output to an image memory. The presence of a fingerprint ridge is detected by virtue of a ring-down oscillation that arises from reflection when an electric field is applied to the piezoelectric thin film sensor array at a pixel in contact with the fingerprint ridge. For example, such a ring-down value associated with a fingerprint ridge can be detected at about 150 ns. (or 5 cycles at 30 MHZ). Other reflections indicative of additional biometrics (e.g. from tissue, blood, bone, fingernail, etc.) can also be detected. A Doppler effect due to reflections from circulating blood can also be detected. Such a Doppler effect can provide further information about direction and speed of blood circulation. An instantaneous pyroelectric effect can also be detected to indicate a live finger presence.
Patent JP-4242095-B2 (JP)
IPC: B61C15/10
Filed: 2001-03-14
Granted: 2009-03-18
Abstract: Problems are posed by slip prevention particle injection devices by wheels of railway rolling stock. Namely, if the injected quantity of slippage-preventing particles is adjusted so as not to be excessive and to be a suitable quantity, it is not possible to obtain a predetermined injection pressure and it is not possible to inject the particles at the target location. The injector device of the present invention is constituted by providing an air through-flow duct 5 inside a particle retainer tank 1, and connecting an air supply duct 17 to this air through-flow duct 5. In the above mentioned tank 1, in addition to an air inflow duct 6 being provided in the vicinity of the inlet side of the air through-flow duct 5, an air discharge duct 18 is provided in the vicinity of the outlet side of the air through-flow duct 5. This air inflow duct 6 and air discharge duct 18 are connected to the air through-flow duct 5 and one end of these ducts 6 and 18 is open into the tank 1. Further, in addition to a mixing chamber 15 and a smaller-diameter air passage section 9 being provided in the air through-flow duct 5, a particle introduction hole 16 is provided in the mixing chamber 15, and an injector duct 21 that injects a fluid mixture of slippage-preventing particles and compressed air is provided at the outlet side of the air through-flow duct 5. <IMAGE>